OJP-2028

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameOJP-2028
Drug Alias NameOJP-2028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJeil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJeil Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeN/A
Related LinksN/A